Development of nanoparticle-bound arylsulfatase B for enzyme replacement therapy of mucopolysaccharidosis VI

Author： Mühlstein A. Gelperina S. Kreuter J.

ISSN： 0031-7144

Source： Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.68, Iss.7, 2013-07, pp. : 549-554

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Arylsulfatase A bound to poly(butyl cyanoacrylate) nanoparticles for enzyme replacement therapy – physicochemical evaluation

By Mühlstein A. Gelperina S. Shipulo E. Maksimenko O. Kreuter J.

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 7, 2014-07 ,pp. : 518-524

Govi-Verlag

Access to resources Recommend Favorite

The first 5years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I

By Wraith J E

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 3, 2005-03 ,pp. : 489-506

Informa Healthcare

Access to resources Recommend Favorite

Intrathecal Enzyme Replacement Therapy for Mucopolysaccharidosis I: Translating Success in Animal Models to Patients

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 6, 2011-06 ,pp. : 946-955

Bentham Science Publishers

Access to resources Recommend Favorite

Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier

By Kreuter Jörg Shamenkov Dmitry Petrov Valery Ramge Peter Cychutek Klaus Koch-Brandt Claudia Alyautdin Renad

Journal of Drug Targeting, Vol. 10, Iss. 4, 2002-01 ,pp. : 317-325

Informa Healthcare

Access to resources Recommend Favorite

Enzyme replacement therapy for the mucopolysaccharide storage disorders

By Kakkis Emil

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 5, 2002-05 ,pp. : 675-685

Informa Healthcare

Access to resources Recommend Favorite